Ultragenyx Pharmaceutical

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RARE and other ETFs, options, and stocks.

About RARE

Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, engaged in the identification, acquisition, development and commercialization of novel products for the treatment of serious rare and ultra-rare genetic diseases. Its products include Mepsevii and Crysvita. 

CEO
Emil D. Kakkis
CEOEmil D. Kakkis
Employees
1,119
Employees1,119
Headquarters
Novato, California
HeadquartersNovato, California
Founded
2010
Founded2010
Employees
1,119
Employees1,119

RARE Key Statistics

Market cap
2.88B
Market cap2.88B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
592.24K
Average volume592.24K
High today
$42.07
High today$42.07
Low today
$40.34
Low today$40.34
Open price
$40.62
Open price$40.62
Volume
135.70K
Volume135.70K
52 Week high
$95.37
52 Week high$95.37
52 Week low
$39.75
52 Week low$39.75

Analyst ratings

71%

of 17 ratings
Buy
70.6%
Hold
29.4%
Sell
0%

RARE Earnings

-$2.26
-$1.51
-$0.75
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 1, After Hours
ActualExpected Nov 1, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.